Role of hepatitis B virus non-structural protein HBx on HBV replication, interferon signaling, and hepatocarcinogenesis
Hepatitis B, a global health concern caused by the hepatitis B virus (HBV), infects nearly 2 billion individuals worldwide, as reported by the World Health Organization (WHO). HBV, a hepatotropic DNA virus, predominantly targets and replicates within hepatocytes. Those carrying the virus are at incr...
| Published in: | Frontiers in Microbiology |
|---|---|
| Main Authors: | Fei Wang, Hongxiao Song, Fengchao Xu, Jing Xu, Le Wang, Fan Yang, Yujia Zhu, Guangyun Tan |
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2023-12-01
|
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmicb.2023.1322892/full |
Similar Items
NF-κB-Dependent IFIT3 Induction by HBx Promotes Hepatitis B Virus Replication
by: Fengchao Xu, et al.
Published: (2019-10-01)
by: Fengchao Xu, et al.
Published: (2019-10-01)
When Hepatitis B Virus Meets Interferons
by: Guangyun Tan, et al.
Published: (2018-07-01)
by: Guangyun Tan, et al.
Published: (2018-07-01)
Cholesterol metabolism regulator SREBP2 inhibits HBV replication via suppression of HBx nuclear translocation
by: Fan Yang, et al.
Published: (2025-01-01)
by: Fan Yang, et al.
Published: (2025-01-01)
HBV-related HCC development in mice is STAT3 dependent and indicates an oncogenic effect of HBx
by: Marc Ringelhan, et al.
Published: (2024-10-01)
by: Marc Ringelhan, et al.
Published: (2024-10-01)
Role of epigenetic modification in interferon treatment of hepatitis B virus infection
by: Zhijing Yang, et al.
Published: (2022-10-01)
by: Zhijing Yang, et al.
Published: (2022-10-01)
Antiviral effects of interferon-stimulated genes in bats
by: Dan Zhang, et al.
Published: (2023-08-01)
by: Dan Zhang, et al.
Published: (2023-08-01)
Identification of interferon-stimulated genes with modulated expression during hepatitis E virus infection in pig liver tissues and human HepaRG cells
by: Léa Meyer, et al.
Published: (2023-11-01)
by: Léa Meyer, et al.
Published: (2023-11-01)
Are Humanized Mouse Models Useful for Basic Research of Hepatocarcinogenesis through Chronic Hepatitis B Virus Infection?
by: Masataka Tsuge
Published: (2021-09-01)
by: Masataka Tsuge
Published: (2021-09-01)
STAT3-Dependent Gene TRIM5γ Interacts With HBx Through a Zinc Binding Site on the BBox Domain
by: Hongxiao Song, et al.
Published: (2021-07-01)
by: Hongxiao Song, et al.
Published: (2021-07-01)
Human Cytomegalovirus UL23 Antagonizes the Antiviral Effect of Interferon-γ by Restraining the Expression of Specific IFN-Stimulated Genes
by: Hankun Wang, et al.
Published: (2023-04-01)
by: Hankun Wang, et al.
Published: (2023-04-01)
Mechanisms underlying the compromised clinical efficacy of interferon in clearing HBV
by: Zhuoyan Lei, et al.
Published: (2024-12-01)
by: Zhuoyan Lei, et al.
Published: (2024-12-01)
Airways tissue expression of type I interferons and their stimulated genes is higher in children than adults
by: Narjes Saheb Sharif-Askari, et al.
Published: (2022-11-01)
by: Narjes Saheb Sharif-Askari, et al.
Published: (2022-11-01)
Antiviral Effects of Avian Interferon-Stimulated Genes
by: Xingchen He, et al.
Published: (2024-10-01)
by: Xingchen He, et al.
Published: (2024-10-01)
Gambogic acid inhibits HBx-mediated hepatitis B virus replication by targeting the DTX1-Notch signaling pathway
by: Xu Wen, et al.
Published: (2024-01-01)
by: Xu Wen, et al.
Published: (2024-01-01)
Cytosolic DNA sensors activation of human astrocytes inhibits herpes simplex virus through IRF1 induction
by: Yu Liu, et al.
Published: (2024-05-01)
by: Yu Liu, et al.
Published: (2024-05-01)
HBx Mediated Increase of DDX17 Contributes to HBV-Related Hepatocellular Carcinoma Tumorigenesis
by: Mei-Ling Dong, et al.
Published: (2022-06-01)
by: Mei-Ling Dong, et al.
Published: (2022-06-01)
Chasing Virus Replication and Infection: PAMP-PRR Interaction Drives Type I Interferon Production, Which in Turn Activates ISG Expression and ISGylation
by: Imaan Muhammad, et al.
Published: (2025-04-01)
by: Imaan Muhammad, et al.
Published: (2025-04-01)
AEN Suppresses the Replication of Porcine Epidemic Diarrhea Virus by Inducing the Expression of Type I IFN and ISGs in MARC-145 Cells
by: Miao Luo, et al.
Published: (2023-12-01)
by: Miao Luo, et al.
Published: (2023-12-01)
Hepatitis B Viral Protein HBx: Roles in Viral Replication and Hepatocarcinogenesis
by: Dong Li, et al.
Published: (2024-08-01)
by: Dong Li, et al.
Published: (2024-08-01)
Interferon response and profiling of interferon response genes in peripheral blood of vaccine-naive COVID-19 patients
by: Baozhen Huang, et al.
Published: (2024-01-01)
by: Baozhen Huang, et al.
Published: (2024-01-01)
The Role of Sustained Type I Interferon Secretion in Chronic HIV Pathogenicity: Implications for Viral Persistence, Immune Activation, and Immunometabolism
by: Eman Teer, et al.
Published: (2025-01-01)
by: Eman Teer, et al.
Published: (2025-01-01)
Forms and Methods for Interferon’s Encapsulation
by: Thelvia I. Ramos, et al.
Published: (2021-09-01)
by: Thelvia I. Ramos, et al.
Published: (2021-09-01)
Interferon-alpha responsible EPN3 regulates hepatitis B virus replication
by: Xueqian Li, et al.
Published: (2022-07-01)
by: Xueqian Li, et al.
Published: (2022-07-01)
Interferon Status and Choice of Interferons Inducers in Frequently Ill Children
by: M. S. Savenkovа, et al.
Published: (2016-06-01)
by: M. S. Savenkovа, et al.
Published: (2016-06-01)
JMJD2D stabilises and cooperates with HBx protein to promote HBV transcription and replication
by: Xu Kong, et al.
Published: (2023-10-01)
by: Xu Kong, et al.
Published: (2023-10-01)
Lamin A/C promotes HBV transcription by modulating histone modification associated with cccDNA minichromosome in an HBx-dependent manner
by: Linshan Jiang, et al.
Published: (2025-06-01)
by: Linshan Jiang, et al.
Published: (2025-06-01)
Insights of HBV Pathogenesis and Emerging Clinical Therapies for HBV Induced HCC Patients for a Better Prognostic Outcome
by: Reshmi Chatterjee
Published: (2015-02-01)
by: Reshmi Chatterjee
Published: (2015-02-01)
An Evaluation of Type 1 Interferon Related Genes in Male and Female-Matched, SARS-CoV-2 Infected Individuals Early in the COVID-19 Pandemic
by: Tom P. Huecksteadt, et al.
Published: (2024-03-01)
by: Tom P. Huecksteadt, et al.
Published: (2024-03-01)
Canonical and Divergent N-Terminal HBx Isoform Proteins Unveiled: Characteristics and Roles during HBV Replication
by: Sergio Hernández, et al.
Published: (2021-11-01)
by: Sergio Hernández, et al.
Published: (2021-11-01)
Interferon-induced miR-7705 modulates the anti-virus activity of cholesterol 25-hydroxylase
by: Le Wang, et al.
Published: (2025-09-01)
by: Le Wang, et al.
Published: (2025-09-01)
HBx promotes tumorigenicity through RRM2-mediated autophagy in hepatocellular carcinoma
by: Yaqun Li, et al.
Published: (2024-09-01)
by: Yaqun Li, et al.
Published: (2024-09-01)
Perspectives on NcRNAs in HBV/cccDNA-driven HCC progression
by: Yang-Hsiang Lin, et al.
Published: (2025-06-01)
by: Yang-Hsiang Lin, et al.
Published: (2025-06-01)
Proteomic Analysis of ISGylation in Immortalized Porcine Alveolar Macrophage Cell Lines Induced by Type I Interferon
by: Chengbo Zhu, et al.
Published: (2021-02-01)
by: Chengbo Zhu, et al.
Published: (2021-02-01)
Pin-Pointing the Key Hubs in the IFN-γ Pathway Responding to SARS-CoV-2 Infection
by: Ayelen Toro, et al.
Published: (2022-09-01)
by: Ayelen Toro, et al.
Published: (2022-09-01)
HBV X Protein Induces Degradation of UBXN7, a Novel Negative Regulator of NF-κB Signaling, to Promote HBV ReplicationSummary
by: Sen Yuan, et al.
Published: (2023-01-01)
by: Sen Yuan, et al.
Published: (2023-01-01)
Nonsynonymous C1653T Mutation of Hepatitis B Virus X Gene Enhances Malignancy of Hepatocellular Carcinoma Cells
by: Zhang C, et al.
Published: (2022-05-01)
by: Zhang C, et al.
Published: (2022-05-01)
Determinants of functional cure in interferon-treated chronic hepatitis B: a retrospective cohort analysis of HBsAg dynamics and clinical predictors
by: Daqiong Zhou, et al.
Published: (2025-06-01)
by: Daqiong Zhou, et al.
Published: (2025-06-01)
Effectiveness of add-on Pegylated interferon alfa-2a therapy in a Lamivudine-treated patient with chronic hepatitis B
by: Mangano Carmelo, et al.
Published: (2011-01-01)
by: Mangano Carmelo, et al.
Published: (2011-01-01)
Mechanism of HBx Protein Inhibiting DKK4 Expression and Its Effect on Proliferation and Migration of Hepatocarcinoma Cell Lines
by: ZHANG Wenjing, et al.
Published: (2022-09-01)
by: ZHANG Wenjing, et al.
Published: (2022-09-01)
Interferons in Autoimmunity: From Loss of Tolerance to Chronic Inflammation
by: Grigore Mihaescu, et al.
Published: (2025-10-01)
by: Grigore Mihaescu, et al.
Published: (2025-10-01)
Similar Items
-
NF-κB-Dependent IFIT3 Induction by HBx Promotes Hepatitis B Virus Replication
by: Fengchao Xu, et al.
Published: (2019-10-01) -
When Hepatitis B Virus Meets Interferons
by: Guangyun Tan, et al.
Published: (2018-07-01) -
Cholesterol metabolism regulator SREBP2 inhibits HBV replication via suppression of HBx nuclear translocation
by: Fan Yang, et al.
Published: (2025-01-01) -
HBV-related HCC development in mice is STAT3 dependent and indicates an oncogenic effect of HBx
by: Marc Ringelhan, et al.
Published: (2024-10-01) -
Role of epigenetic modification in interferon treatment of hepatitis B virus infection
by: Zhijing Yang, et al.
Published: (2022-10-01)
